US20120095554A1 - Compressed haptics - Google Patents

Compressed haptics Download PDF

Info

Publication number
US20120095554A1
US20120095554A1 US13/338,440 US201113338440A US2012095554A1 US 20120095554 A1 US20120095554 A1 US 20120095554A1 US 201113338440 A US201113338440 A US 201113338440A US 2012095554 A1 US2012095554 A1 US 2012095554A1
Authority
US
United States
Prior art keywords
haptics
optics
intraocular implant
injectable intraocular
facing wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/338,440
Inventor
Eli Aharoni
Yossi Gross
Gideon Dotan
Iden Avihar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VisionCare Ophthalmic Technologies Inc
Original Assignee
VisionCare Ophthalmic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VisionCare Ophthalmic Technologies Inc filed Critical VisionCare Ophthalmic Technologies Inc
Priority to US13/338,440 priority Critical patent/US20120095554A1/en
Publication of US20120095554A1 publication Critical patent/US20120095554A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1662Instruments for inserting intraocular lenses into the eye
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1662Instruments for inserting intraocular lenses into the eye
    • A61F2/167Instruments for inserting intraocular lenses into the eye with pushable plungers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1662Instruments for inserting intraocular lenses into the eye
    • A61F2/1675Instruments for inserting intraocular lenses into the eye with a lubricated inner surface, e.g. the lubricant being coated on the inner surface or being injected through a port
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1662Instruments for inserting intraocular lenses into the eye
    • A61F2/1678Instruments for inserting intraocular lenses into the eye with a separate cartridge or other lens setting part for storage of a lens, e.g. preloadable for shipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0071Additional features; Implant or prostheses properties not otherwise provided for breakable or frangible

Definitions

  • the present invention relates to ocular implants generally and more particularly to intraocular implants.
  • the present invention seeks to provide an improved intraocular implant.
  • an injectable intraocular implant including an optics portion and a resilient, flexible haptics portion mounted coaxially with the optics portion.
  • the optics portion and the haptics portion are arranged for mutual snap fit engagement.
  • the optics portion includes a telescope.
  • the haptics portion is formed of biocompatible plastic.
  • the haptics portion includes a cylindrical portion having integrally formed therewith a plurality of outwardly extending haptics wings.
  • the haptics portion includes an outwardly extending helical portion including at least one helical section.
  • each of the at least one helical section includes a haptics spiral portion, a residual spiral portion and a frangible portion connecting the haptics spiral portion and the residual spiral portion.
  • the haptics portion includes a hollow, generally cylindrical structure defining a generally circular inward facing wall portion and a generally circular outward facing wall portion. Additionally, the inward facing wall portion defines a generally circular optics engagement aperture therein. Alternatively, the inward facing wall portion and the outward facing wall portion each define a generally circular optics engagement aperture therein.
  • a method for inserting an intraocular implant into an eye including providing an injectable intraocular implant including an optics portion and a resilient, flexible haptics portion mounted coaxially with the optics portion, locating the injectable intraocular implant in a delivery tube of a syringe, inserting the delivery tube of a syringe into a lens capsule of an eye and injecting the injectable intraocular implant into the lens capsule.
  • the injecting includes utilizing fluid pressure to force the implant into the lens capsule.
  • the fluid is biocompatible fluid.
  • the haptics include haptics wings and the locating includes folding the haptics wings over the optics portion.
  • the locating includes arranging the implant with an outward facing end of the optics portion arranged rearward in the delivery tube.
  • the haptics portion includes an outwardly extending helical portion and the locating includes winding the helical portion into a coil. Additionally, the injecting includes rotating the syringe.
  • the outwardly extending helical portion includes a haptics spiral portion, a residual spiral portion and a frangible portion connecting the haptics spiral portion and the residual spiral portion and the rotating causes the frangible portion to break, thereby separating the haptics spiral portion from the residual spiral portion.
  • the haptics portion includes an outward facing wall portion and the locating includes pulling the outward facing wall portion over an outward facing end of the optics portion. Additionally, the locating includes sealing a fluid flow passageway in the syringe. Additionally, the injecting includes unsealing the fluid flow passageway.
  • the locating includes drawing the haptics portion into a delivery syringe.
  • the method also includes puncturing the haptics portion.
  • FIGS. 1A and 1B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with a preferred embodiment of the present invention
  • FIGS. 1C and 1D are simplified respective exploded and assembled side view illustrations of the injectable intraocular implant of FIGS. 1A & 1B ;
  • FIGS. 2 and 3 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a fluid-filled hypodermic delivery syringe;
  • FIGS. 4A , 4 B, 4 C and 4 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 2 & 3 into the eye of a patient;
  • FIGS. 5 and 6 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a specially designed, non fluid-filled hypodermic delivery syringe;
  • FIGS. 7A , 7 B, 7 C and 7 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 5 & 6 into the eye of a patient;
  • FIGS. 8A and 8B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with another preferred embodiment of the present invention.
  • FIGS. 8C and 8D are simplified respective exploded and assembled side view illustrations of the injectable intraocular implant of FIGS. 8A & 8B ;
  • FIGS. 9 and 10 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 8A-8D located in a hypodermic delivery syringe;
  • FIGS. 11A , 11 B, 11 C and 11 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient;
  • FIGS. 12A , 12 B, 12 C and 12 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient in accordance with another preferred embodiment of the present invention;
  • FIGS. 13A and 13B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with yet another preferred embodiment of the present invention.
  • FIG. 13C is a simplified assembled side view illustration of the injectable intraocular implant of FIGS. 13A & 13B ;
  • FIGS. 14A and 14B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 13A-13C located in a delivery syringe;
  • FIGS. 15A , 15 B, 15 C and 15 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 13A-13C in the delivery syringe arrangement of FIGS. 14A & 14B into the eye of a patient;
  • FIGS. 16A and 16B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with still another preferred embodiment of the present invention.
  • FIG. 16C is a simplified assembled side view illustration of the injectable intraocular implant of FIGS. 16A & 16B ;
  • FIGS. 17A and 17B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a delivery syringe;
  • FIGS. 18A , 18 B, 18 C and 18 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 17A & 17B into the eye of a patient;
  • FIGS. 19A and 19B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a delivery syringe;
  • FIGS. 20A , 20 B, 20 C and 20 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 19A & 19B into the eye of a patient.
  • FIGS. 1A-1D illustrate an injectable intraocular implant constructed and operative in accordance with a preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 100 and a haptics portion 102 which is preferably snap-fitted onto the optics portion 100 .
  • the optics portion 100 may be any suitable optics portion and is preferably, but not necessarily, a telescope.
  • Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • the optics portion 100 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the outward facing end 110 , a peripheral groove 112 .
  • the haptics portion 102 is preferably formed of a resilient, flexible material, such as biocompatible plastic, and includes a cylindrical portion 124 having integrally formed therewith a plurality of outwardly extending haptics wings 126 .
  • Cylindrical portion 124 is preferably formed with an inwardly directed peripheral protrusion 128 adjacent one end thereof, hereinafter referred to as the outward facing end 130 .
  • Protrusion 128 is arranged for normally non-removable snap-fit engagement with groove 112 on optics portion 100 , when cylindrical portion 124 is in coaxial surrounding relationship with optics portion 100 as shown.
  • peripheral groove 112 of the optics portion 100 may be located at any suitable location therealong and the inwardly directed peripheral protrusion 128 of cylindrical portion 124 of haptics portion 102 may be located at any suitable location therealong to provide normally non-removable snap-fit engagement of optics portion 100 and haptics portion 102 .
  • FIGS. 2 and 3 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a fluid-filled hypodermic delivery syringe 140 . It is seen that haptics wings 126 are folded over the optics portion 100 and that the implant is arranged with outward facing ends 110 and 130 arranged rearward in a delivery tube 142 of delivery syringe 140 . Fluid, such as biocompatible fluid 144 , is located forward of a piston 146 of delivery syringe 140 and rearward of the implant.
  • FIGS. 4A , 4 B, 4 C and 4 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 2 & 3 into the eye of a patient.
  • FIG. 4A shows initial insertion of the tip of the delivery tube 142 of delivery syringe 140 into the lens capsule of the eye.
  • FIG. 4B shows the implant being forced out of the delivery syringe 140 into the lens capsule.
  • FIG. 4C shows unfolding of haptics wings 126 inside the lens capsule and
  • FIG. 4D shows proper orientation of the implant, including fully deployed haptics wings 126 , within the lens capsule.
  • FIGS. 5 and 6 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a specially designed, non fluid-filled hypodermic delivery syringe 160 . It is seen that haptics wings 126 are folded over the optics portion 100 and that the implant is arranged with outward facing ends 110 and 130 arranged rearward in a delivery tube 162 of delivery syringe 160 . A piston 166 of delivery syringe 160 engages outward facing end 110 of the optics portion 100 of the implant.
  • FIGS. 7A , 7 B, 7 C and 7 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 5 & 6 into the eye of a patient.
  • FIG. 7A shows initial insertion of the tip of the delivery tube 162 of delivery syringe 160 into the lens capsule of the eye.
  • FIG. 7B shows the implant being forced out of the delivery syringe 160 into the lens capsule.
  • FIG. 7C shows unfolding of haptics wings 126 inside the lens capsule and
  • FIG. 7D shows proper orientation of the implant, including fully deployed haptics wings 126 , within the lens capsule.
  • FIGS. 8A-8D illustrate an injectable intraocular implant constructed and operative in accordance with another preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 200 and a haptics portion 202 which is preferably snap-fitted onto the optics portion 200 .
  • the optics portion 200 may be any suitable optics portion and is preferably, but not necessarily, a telescope.
  • Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • the optics portion 200 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the inward facing end 210 , a peripheral groove 212 .
  • the haptics portion 202 is preferably formed of a resilient, flexible material, such as biocompatible plastic, and includes a generally cylindrical optics engagement portion 220 integrally formed with an outwardly extending helical portion 222 and a generally cylindrical end portion 224 .
  • Cylindrical optics engagement portion 220 is preferably formed with an inwardly directed peripheral protrusion 228 adjacent one end thereof, hereinafter referred to as the inward facing end 230 .
  • Protrusion 228 is arranged for normally non-removable snap-fit engagement with groove 212 on optics portion 200 , when cylindrical optics engagement portion 220 is in coaxial surrounding relationship with optics portion 200 as shown.
  • peripheral groove 212 of the optics portion 200 may be located at any suitable location therealong and the inwardly directed peripheral protrusion 228 of cylindrical optics engagement portion 220 of haptics portion 202 may be located at any suitable location therealong to provide normally non-removable snap-fit engagement of optics portion 200 and haptics portion 202 .
  • outwardly extending helical portion 222 preferably includes at least one, and preferably two or more, helical section 234 joined at one end to generally cylindrical optics engagement portion 220 and at an opposite end thereof to generally cylindrical end portion 224 .
  • Each of the at least one helical sections 234 preferably include a haptics spiral portion 236 connected to residual spiral portion 238 at a notched frangible portion 240 .
  • Notched frangible portions 240 provide for separation of haptics spiral portions 236 from residual spiral portion 238 , as described hereinbelow with reference to FIG. 11B .
  • notched frangible portion 240 and residual spiral portion 238 may be obviated and haptics spiral portion 236 may be joined directly to generally cylindrical end portion 224 .
  • end portion 224 is also injected into the lens capsule of an eye, as described hereinbelow with reference to FIGS. 12A-12D .
  • cylindrical end portion 224 is placed into a delivery syringe 250 and outwardly extending helical portion 222 is wound, as indicated by arrows 252 ( FIG. 8A ), into a tightly coiled position inside delivery syringe 250 .
  • cylindrical optics engagement portion 220 is then placed into snap fit engagement with optics portion 200 .
  • FIGS. 9 and 10 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 8A-8D located in delivery syringe 250 . It is seen that outwardly extending helical portion 222 of haptics portion 202 is coiled over the optics portion 200 and that the implant is arranged with inward facing ends 210 and 230 arranged forwardly in a delivery tube 254 of delivery syringe 250 . A piston 256 of delivery syringe 250 engages generally cylindrical end portion 224 of haptics portion 202 .
  • FIGS. 11A , 11 B, 11 C and 11 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient.
  • FIG. 11A shows initial insertion of the tip of the delivery tube 254 of delivery syringe 250 into the lens capsule of the eye.
  • FIG. 11B shows the implant being forced out of the delivery syringe 250 into the lens capsule.
  • haptics spiral portion 236 uncoils and extends outwardly into the lens capsule upon exiting delivery syringe 250 .
  • delivery syringe 250 is rotated, as designated by arrow 260 , causing frangible portion 240 to break and separating haptics spiral portion 236 and residual spiral portion 238 .
  • haptics spiral portion 236 remains in the lens capsule together with optics portion 200 , while residual spiral portion 238 remains within delivery syringe 250 , which is then removed from the eye.
  • FIG. 11D shows proper orientation of the implant, including fully deployed haptics spiral portion 236 of haptics portion 202 and optics portion 200 , within the lens capsule.
  • FIGS. 12A , 12 B, 12 C and 12 D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient in accordance with another preferred embodiment of the present invention.
  • haptics spiral portion 236 of the at least one helical section 234 is preferably joined at one end to generally cylindrical optics engagement portion 220 and at an opposite end thereof to generally cylindrical end portion 224 , and helical section 234 preferably does not include a notched frangible portion 240 and residual spiral portion 238 .
  • helical section 234 may also include a notched frangible portion 240 and a residual spiral portion 238 joined to end portion 224 .
  • FIG. 12A shows initial insertion of the tip of the delivery tube 254 of delivery syringe 250 into the lens capsule of the eye.
  • FIG. 12B shows the implant being forced out of the delivery syringe 250 into the lens capsule.
  • haptics spiral portion 236 uncoils and extends outwardly into the lens capsule upon exiting delivery syringe 250 .
  • the embodiment of FIG. 12B differs from the embodiment of FIG. 11B in that delivery syringe 250 is not rotated to break notched frangible portion 240 and the entire haptics portion 202 is injected into the lens capsule.
  • delivery syringe 250 is removed from the eye and outwardly extending helical portion 222 uncoils to its original form providing proper orientation of the implant, including fully deployed haptics spiral portion 236 of haptics portion 202 and optics portion 200 , within the lens capsule.
  • FIGS. 13A-13C illustrate an injectable intraocular implant constructed and operative in accordance with yet another preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 300 and a haptics portion 302 which is preferably snap-fitted onto the optics portion 300 .
  • the optics portion 300 may be any suitable optics portion and is preferably, but not necessarily, a telescope.
  • Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • the optics portion 300 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the inward facing end 310 , a peripheral groove 312 .
  • the haptics portion 302 is preferably formed of a resilient, flexible material, with a hollow, generally cylindrical structure defining a generally circular inward facing wall portion 314 and a generally circular outward facing wall portion 316 .
  • Each of wall portions 314 and 316 preferably define a generally circular optics engagement aperture 320 therein.
  • Each of wall portions 314 and 316 is preferably formed with an inwardly directed peripheral protrusion 328 adjacent optics engagement aperture 320 thereof.
  • Protrusion 328 of wall portion 314 is arranged for normally non-removable snap-fit engagement with groove 312 of optics portion 300 , when haptics portion 302 is in coaxial surrounding relationship with optics portion 300 as shown.
  • Protrusion 328 of wall portion 316 is arranged for engagement of wall portion 316 with a delivery syringe as described further hereinbelow.
  • haptics portion 302 is preferably formed of a transparent material, it may be formed with non-transparent portions as suitable to eliminate and/or reduce glare.
  • FIGS. 14A and 14B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 13A-13C located in a delivery syringe and to FIGS. 15A , 15 B, 15 C and 15 D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 13A-13C in the delivery syringe arrangement of FIGS. 14A & 14B into the eye of a patient.
  • outward facing wall portion 316 of haptics portion 302 is pulled over an outward facing end 330 of optics portion 300 and drawn into engagement with an outer wall 340 of a delivery syringe 350 .
  • outer wall 340 preferably includes an inwardly directed peripheral protrusion 352 which engages protrusion 328 of wall portion 316 and thereby secures wall portion 316 of haptics portion 302 to delivery syringe 350 .
  • the pulling of wall portion 316 causes haptics portion 302 to be temporarily deformed into an elongated generally cylindrical orientation overlying optics portion 300 .
  • Delivery syringe 350 preferably also includes a fluid flow passageway 354 in fluid communication with a rearward facing wall 356 of syringe 350 at a location 358 .
  • Fluid flow passageway 354 is also preferably in fluid communication with a vacuum pump (not shown) via a tube 360 .
  • FIG. 15A shows initial insertion of delivery syringe 350 into the lens capsule of the eye. It is appreciated that the operation of the vacuum pump allows haptics portion 302 to closely overly optics portion 300 .
  • haptics portion 302 of the implant expands outwardly from the optics portion 300 as wall portions 314 and 316 of haptics portion 302 return to their original generally circular orientation.
  • the unsealing of fluid flow passageway 354 allows air to flow therethrough and into the space formed between haptics portion 302 and optics portion 300 , causing expansion of haptics portion 302 and causing outer wall 340 of delivery syringe 350 to disengage from protrusion 328 of wall portion 316 of haptics portion 302 .
  • delivery syringe 350 is removed from the eye and haptics portion 302 returns to its original form providing proper orientation of the implant, including fully deployed haptics portion 302 and optics portion 300 , within the lens capsule.
  • FIGS. 16A-16C illustrate an injectable intraocular implant constructed and operative in accordance with yet another preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 400 and a haptics portion 402 which is preferably snap-fitted or shrink-fitted onto the optics portion 400 .
  • the optics portion 400 may be any suitable optics portion and is preferably, but not necessarily, a telescope.
  • Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • the optics portion 400 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the inward facing end 410 , a peripheral groove 412 .
  • the haptics portion 402 is preferably formed of a resilient, flexible material, with a hollow, generally cylindrical structure defining a generally circular inward facing wall portion 414 and a generally circular outward facing wall portion 416 .
  • Wall portion 414 preferably defines a generally circular optics engagement aperture 420 therein.
  • Wall portion 414 is preferably formed with an inwardly directed peripheral protrusion 428 adjacent optics engagement aperture 420 .
  • Protrusion 428 of wall portion 414 is arranged for normally non-removable snap-fit or tension-fit engagement with groove 412 of optics portion 400 , when haptics portion 402 is in coaxial surrounding relationship with optics portion 400 as shown.
  • haptics portion 402 is preferably formed of a transparent material, it may be formed with non-transparent portions as suitable to eliminate and/or reduce glare.
  • FIGS. 17A and 17B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a delivery syringe and to FIGS. 18A , 18 B, 18 C and 18 D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 17A & 17B into the eye of a patient.
  • outward facing wall portion 416 of haptics portion 402 is drawn into a vacuum delivery syringe 450 by extending a plunger 456 in the direction of arrow 458 .
  • the drawing of wall portion 416 into delivery syringe 450 causes haptics portion 402 to be temporarily deformed into an elongated generally cylindrical orientation overlying optics portion 400 .
  • FIG. 18A shows initial insertion of delivery syringe 450 into the lens capsule of the eye, in the direction of arrow 460 . It is appreciated that maintaining plunger 456 in the position of FIGS. 17A-17B maintains the vacuum inside delivery syringe 450 and allows haptics portion 402 to closely overly optics portion 400 during initial insertion of syringe 450 into the lens capsule.
  • haptics portion 402 of the implant is released from syringe 450 .
  • haptics portion 402 expands outwardly from the optics portion 400 as wall portions 414 and 416 of haptics portion 402 return to their original generally circular orientation.
  • an aperture is made in wall portion 416 , preferably through puncturing wall portion 416 with a hook 468 , to allow aqueous fluid from the eye to flow into the area between optics portion 400 and haptics portion 402 .
  • haptics portion 402 fills with aqueous fluid 470 and returns to its original form providing proper orientation of the implant, including fully deployed haptics portion 402 and optics portion 400 , within the lens capsule.
  • FIGS. 19A and 19B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a fluid-filled delivery syringe and to FIGS. 20A , 20 B, 20 C and 20 D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 19A & 19B into the eye of a patient.
  • outward facing wall portion 416 of haptics portion 402 is pulled over an outward facing end 490 of optics portion 400 and the intraocular implant is inserted into a fluid-filled delivery syringe 500 .
  • the pulling of wall portion 416 over end 490 causes haptics portion 402 to be temporarily deformed into an elongated generally cylindrical orientation overlying optics portion 400 .
  • Fluid such as biocompatible fluid 504 , is located forward of a piston 506 of delivery syringe 500 and rearward of the implant.
  • haptics portion 402 may be filled, using any suitable method, with any suitable biocompatible fluid 510 , such as saline or air, prior to insertion into delivery syringe 500 . It is further appreciated that insertion of fluid 510 into haptics portion 402 provides cushioning for the intraocular implant during the injection thereof into an eye.
  • biocompatible fluid 510 such as saline or air
  • FIG. 20A shows initial insertion of the tip of delivery syringe 500 into the lens capsule of the eye. It is appreciated that the temporary deforming of haptics portion 402 allows haptics portion 402 to closely overly optics portion 400 inside syringe 500 .
  • the implant is forced out of the syringe 500 into the lens capsule.
  • haptics portion 402 expands outwardly from the optics portion 400 as wall portions 414 and 416 of haptics portion 402 return to their generally circular orientation.
  • Syringe 500 is subsequently removed from the lens capsule.
  • an aperture is made in wall portion 416 , preferably through puncturing wall portion 416 with a hook 518 , to allow aqueous fluid from the eye to flow into the area between optics portion 400 and haptics portion 402 and mix with biocompatible fluid 510 .
  • haptics portion 402 is not filled with biocompatible fluid 510 prior to insertion into delivery syringe 500 and the puncturing of wall portion 416 allows aqueous fluid from the eye to flow into the area between optics portion 400 and haptics portion 402 .
  • haptics portion 402 returns to its original form providing proper orientation of the implant, including fully deployed haptics portion 402 and optics portion 400 , within the lens capsule.

Abstract

An injectable intraocular implant including an optics portion and a resilient, flexible haptics portion mounted coaxially with the optics portion and a method for inserting the implant into the eye.

Description

    REFERENCE TO CO-PENDING APPLICATIONS
  • Applicants hereby make reference to the following co-pending U.S. patent applications, the disclosures of which are hereby incorporated by reference:
  • U.S. Ser. No. 10/321,793, filed Dec. 17, 2002, entitled “Intraocular Implants”; U.S. Ser. No. 10/342,160, filed Jan. 14, 2003, entitled “Intraocular Lens Implant” and U.S. Ser. No. 10/489,388, filed Mar. 11, 2004, entitled “Intraocular Implants.”
  • FIELD OF THE INVENTION
  • The present invention relates to ocular implants generally and more particularly to intraocular implants.
  • BACKGROUND OF THE INVENTION
  • The following patent publications are believed to represent the current state of the art:
  • U.S. Pat. Nos. 5,814,103; 5,876,442; 5,928,283; 6,007,579; 6,066,171; 5,653,751; 6,596,026; 6,464,725; 5,391,202; 5,384,606; 4,074,368; 4,994,082; 5,628,798; 5,222,981; 4,172,297; 5,769,890; 4,892,543; 4,373,218; 4,968,127; 4,759,761; 4,976,732 and 5,769,889;
  • Published U.S. Application 2001/018,612;
  • Published PCT Applications WO 94/07,435; WO 00/38593 and WO 83/01566;
  • Foreign Patent Publications DE 4,403,326; EP 1,092,402; EP 0,419,740; GB 2,181,355; EP 0,897,702; EP 0,212,616; DE 3,428,895 and DE 19,501,444.
  • SUMMARY OF THE INVENTION
  • The present invention seeks to provide an improved intraocular implant.
  • There is thus provided in accordance with a preferred embodiment of the present invention an injectable intraocular implant including an optics portion and a resilient, flexible haptics portion mounted coaxially with the optics portion.
  • Preferably, the optics portion and the haptics portion are arranged for mutual snap fit engagement.
  • Preferably, the optics portion includes a telescope. Additionally or alternatively, the haptics portion is formed of biocompatible plastic.
  • Preferably, the haptics portion includes a cylindrical portion having integrally formed therewith a plurality of outwardly extending haptics wings.
  • Preferably, the haptics portion includes an outwardly extending helical portion including at least one helical section. Additionally, each of the at least one helical section includes a haptics spiral portion, a residual spiral portion and a frangible portion connecting the haptics spiral portion and the residual spiral portion.
  • Alternatively, the haptics portion includes a hollow, generally cylindrical structure defining a generally circular inward facing wall portion and a generally circular outward facing wall portion. Additionally, the inward facing wall portion defines a generally circular optics engagement aperture therein. Alternatively, the inward facing wall portion and the outward facing wall portion each define a generally circular optics engagement aperture therein.
  • There is also provided in accordance with anther preferred embodiment of the present invention a method for inserting an intraocular implant into an eye including providing an injectable intraocular implant including an optics portion and a resilient, flexible haptics portion mounted coaxially with the optics portion, locating the injectable intraocular implant in a delivery tube of a syringe, inserting the delivery tube of a syringe into a lens capsule of an eye and injecting the injectable intraocular implant into the lens capsule.
  • Preferably, the injecting includes utilizing fluid pressure to force the implant into the lens capsule. Additionally, the fluid is biocompatible fluid.
  • Preferably, the haptics include haptics wings and the locating includes folding the haptics wings over the optics portion.
  • Preferably, the locating includes arranging the implant with an outward facing end of the optics portion arranged rearward in the delivery tube.
  • Alternatively, the haptics portion includes an outwardly extending helical portion and the locating includes winding the helical portion into a coil. Additionally, the injecting includes rotating the syringe.
  • Preferably, the outwardly extending helical portion includes a haptics spiral portion, a residual spiral portion and a frangible portion connecting the haptics spiral portion and the residual spiral portion and the rotating causes the frangible portion to break, thereby separating the haptics spiral portion from the residual spiral portion.
  • Alternatively, the haptics portion includes an outward facing wall portion and the locating includes pulling the outward facing wall portion over an outward facing end of the optics portion. Additionally, the locating includes sealing a fluid flow passageway in the syringe. Additionally, the injecting includes unsealing the fluid flow passageway.
  • Preferably, the locating includes drawing the haptics portion into a delivery syringe.
  • Preferably, the method also includes puncturing the haptics portion.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:
  • FIGS. 1A and 1B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with a preferred embodiment of the present invention;
  • FIGS. 1C and 1D are simplified respective exploded and assembled side view illustrations of the injectable intraocular implant of FIGS. 1A & 1B;
  • FIGS. 2 and 3 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a fluid-filled hypodermic delivery syringe;
  • FIGS. 4A, 4B, 4C and 4D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 2 & 3 into the eye of a patient;
  • FIGS. 5 and 6 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a specially designed, non fluid-filled hypodermic delivery syringe;
  • FIGS. 7A, 7B, 7C and 7D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 5 & 6 into the eye of a patient;
  • FIGS. 8A and 8B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with another preferred embodiment of the present invention;
  • FIGS. 8C and 8D are simplified respective exploded and assembled side view illustrations of the injectable intraocular implant of FIGS. 8A & 8B;
  • FIGS. 9 and 10 are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 8A-8D located in a hypodermic delivery syringe;
  • FIGS. 11A, 11B, 11C and 11D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient;
  • FIGS. 12A, 12B, 12C and 12D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient in accordance with another preferred embodiment of the present invention;
  • FIGS. 13A and 13B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with yet another preferred embodiment of the present invention;
  • FIG. 13C is a simplified assembled side view illustration of the injectable intraocular implant of FIGS. 13A & 13B;
  • FIGS. 14A and 14B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 13A-13C located in a delivery syringe;
  • FIGS. 15A, 15B, 15C and 15D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 13A-13C in the delivery syringe arrangement of FIGS. 14A & 14B into the eye of a patient;
  • FIGS. 16A and 16B are simplified respective exploded and assembled pictorial illustrations of an injectable intraocular implant constructed and operative in accordance with still another preferred embodiment of the present invention;
  • FIG. 16C is a simplified assembled side view illustration of the injectable intraocular implant of FIGS. 16A & 16B;
  • FIGS. 17A and 17B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a delivery syringe;
  • FIGS. 18A, 18B, 18C and 18D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 17A & 17B into the eye of a patient;
  • FIGS. 19A and 19B are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a delivery syringe; and
  • FIGS. 20A, 20B, 20C and 20D are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 19A & 19B into the eye of a patient.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • Reference is now made to FIGS. 1A-1D, which illustrate an injectable intraocular implant constructed and operative in accordance with a preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 100 and a haptics portion 102 which is preferably snap-fitted onto the optics portion 100.
  • The optics portion 100 may be any suitable optics portion and is preferably, but not necessarily, a telescope. Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • U.S. Pat. Nos. 5,391,202; 5,354,335; 5,814,103; 5,876,442; 5,928,283; 6,007,579; 6,066,171; 6,569,199 and 6,596,026, and U.S. published applications U.S. Ser. Nos. 10/342,160 and 10/321,793.
  • The optics portion 100 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the outward facing end 110, a peripheral groove 112. The haptics portion 102 is preferably formed of a resilient, flexible material, such as biocompatible plastic, and includes a cylindrical portion 124 having integrally formed therewith a plurality of outwardly extending haptics wings 126. Cylindrical portion 124 is preferably formed with an inwardly directed peripheral protrusion 128 adjacent one end thereof, hereinafter referred to as the outward facing end 130. Protrusion 128 is arranged for normally non-removable snap-fit engagement with groove 112 on optics portion 100, when cylindrical portion 124 is in coaxial surrounding relationship with optics portion 100 as shown.
  • It is appreciated that the peripheral groove 112 of the optics portion 100 may be located at any suitable location therealong and the inwardly directed peripheral protrusion 128 of cylindrical portion 124 of haptics portion 102 may be located at any suitable location therealong to provide normally non-removable snap-fit engagement of optics portion 100 and haptics portion 102.
  • Reference is now made to FIGS. 2 and 3, which are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a fluid-filled hypodermic delivery syringe 140. It is seen that haptics wings 126 are folded over the optics portion 100 and that the implant is arranged with outward facing ends 110 and 130 arranged rearward in a delivery tube 142 of delivery syringe 140. Fluid, such as biocompatible fluid 144, is located forward of a piston 146 of delivery syringe 140 and rearward of the implant.
  • Reference is now made to FIGS. 4A, 4B, 4C and 4D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 2 & 3 into the eye of a patient. FIG. 4A shows initial insertion of the tip of the delivery tube 142 of delivery syringe 140 into the lens capsule of the eye. FIG. 4B shows the implant being forced out of the delivery syringe 140 into the lens capsule. FIG. 4C shows unfolding of haptics wings 126 inside the lens capsule and FIG. 4D shows proper orientation of the implant, including fully deployed haptics wings 126, within the lens capsule.
  • Reference is now made to FIGS. 5 and 6, which are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 1A-1D located in a specially designed, non fluid-filled hypodermic delivery syringe 160. It is seen that haptics wings 126 are folded over the optics portion 100 and that the implant is arranged with outward facing ends 110 and 130 arranged rearward in a delivery tube 162 of delivery syringe 160. A piston 166 of delivery syringe 160 engages outward facing end 110 of the optics portion 100 of the implant.
  • Reference is now made to FIGS. 7A, 7B, 7C and 7D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 1A-1D in the delivery syringe arrangement of FIGS. 5 & 6 into the eye of a patient. FIG. 7A shows initial insertion of the tip of the delivery tube 162 of delivery syringe 160 into the lens capsule of the eye. FIG. 7B shows the implant being forced out of the delivery syringe 160 into the lens capsule. FIG. 7C shows unfolding of haptics wings 126 inside the lens capsule and FIG. 7D shows proper orientation of the implant, including fully deployed haptics wings 126, within the lens capsule.
  • Reference is now made to FIGS. 8A-8D, which illustrate an injectable intraocular implant constructed and operative in accordance with another preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 200 and a haptics portion 202 which is preferably snap-fitted onto the optics portion 200.
  • The optics portion 200 may be any suitable optics portion and is preferably, but not necessarily, a telescope. Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • U.S. Pat. Nos. 5,391,202; 5,354,335; 5,814,103; 5,876,442; 5,928,283; 6,007,579; 6,066,171; 6,569,199 and 6,596,026, and U.S. published applications U.S. Ser. Nos. 10/342,160 and 10/321,793.
  • The optics portion 200 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the inward facing end 210, a peripheral groove 212. The haptics portion 202 is preferably formed of a resilient, flexible material, such as biocompatible plastic, and includes a generally cylindrical optics engagement portion 220 integrally formed with an outwardly extending helical portion 222 and a generally cylindrical end portion 224.
  • Cylindrical optics engagement portion 220 is preferably formed with an inwardly directed peripheral protrusion 228 adjacent one end thereof, hereinafter referred to as the inward facing end 230. Protrusion 228 is arranged for normally non-removable snap-fit engagement with groove 212 on optics portion 200, when cylindrical optics engagement portion 220 is in coaxial surrounding relationship with optics portion 200 as shown.
  • It is appreciated that the peripheral groove 212 of the optics portion 200 may be located at any suitable location therealong and the inwardly directed peripheral protrusion 228 of cylindrical optics engagement portion 220 of haptics portion 202 may be located at any suitable location therealong to provide normally non-removable snap-fit engagement of optics portion 200 and haptics portion 202.
  • As seen in FIG. 8A, outwardly extending helical portion 222 preferably includes at least one, and preferably two or more, helical section 234 joined at one end to generally cylindrical optics engagement portion 220 and at an opposite end thereof to generally cylindrical end portion 224. Each of the at least one helical sections 234 preferably include a haptics spiral portion 236 connected to residual spiral portion 238 at a notched frangible portion 240. Notched frangible portions 240 provide for separation of haptics spiral portions 236 from residual spiral portion 238, as described hereinbelow with reference to FIG. 11B.
  • Alternatively, notched frangible portion 240 and residual spiral portion 238 may be obviated and haptics spiral portion 236 may be joined directly to generally cylindrical end portion 224. In this embodiment, end portion 224 is also injected into the lens capsule of an eye, as described hereinbelow with reference to FIGS. 12A-12D.
  • As seen further in FIGS. 8A, 8B and 8C, prior to injection of the intraocular implant of FIGS. 8A-8D into an eye, generally cylindrical end portion 224 is placed into a delivery syringe 250 and outwardly extending helical portion 222 is wound, as indicated by arrows 252 (FIG. 8A), into a tightly coiled position inside delivery syringe 250. As seen in FIG. 8D, cylindrical optics engagement portion 220 is then placed into snap fit engagement with optics portion 200.
  • Reference is now made to FIGS. 9 and 10, which are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 8A-8D located in delivery syringe 250. It is seen that outwardly extending helical portion 222 of haptics portion 202 is coiled over the optics portion 200 and that the implant is arranged with inward facing ends 210 and 230 arranged forwardly in a delivery tube 254 of delivery syringe 250. A piston 256 of delivery syringe 250 engages generally cylindrical end portion 224 of haptics portion 202.
  • Reference is now made to FIGS. 11A, 11B, 11C and 11D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient.
  • FIG. 11A shows initial insertion of the tip of the delivery tube 254 of delivery syringe 250 into the lens capsule of the eye.
  • FIG. 11B shows the implant being forced out of the delivery syringe 250 into the lens capsule. As seen in FIG. 11B, haptics spiral portion 236 uncoils and extends outwardly into the lens capsule upon exiting delivery syringe 250. Following the exiting of notched frangible portion 240 from delivery syringe 250, delivery syringe 250 is rotated, as designated by arrow 260, causing frangible portion 240 to break and separating haptics spiral portion 236 and residual spiral portion 238.
  • As seen in FIG. 11C, following the separation of haptics spiral portion 236 and residual spiral portion 238, haptics spiral portion 236 remains in the lens capsule together with optics portion 200, while residual spiral portion 238 remains within delivery syringe 250, which is then removed from the eye.
  • FIG. 11D shows proper orientation of the implant, including fully deployed haptics spiral portion 236 of haptics portion 202 and optics portion 200, within the lens capsule.
  • Reference is now made to FIGS. 12A, 12B, 12C and 12D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 8A-8D in the delivery syringe arrangement of FIGS. 9 & 10 into the eye of a patient in accordance with another preferred embodiment of the present invention. In the embodiment of FIGS. 12A-12D, haptics spiral portion 236 of the at least one helical section 234 is preferably joined at one end to generally cylindrical optics engagement portion 220 and at an opposite end thereof to generally cylindrical end portion 224, and helical section 234 preferably does not include a notched frangible portion 240 and residual spiral portion 238. Alternatively, helical section 234 may also include a notched frangible portion 240 and a residual spiral portion 238 joined to end portion 224.
  • FIG. 12A shows initial insertion of the tip of the delivery tube 254 of delivery syringe 250 into the lens capsule of the eye.
  • FIG. 12B shows the implant being forced out of the delivery syringe 250 into the lens capsule. As seen in FIG. 12B, haptics spiral portion 236 uncoils and extends outwardly into the lens capsule upon exiting delivery syringe 250. The embodiment of FIG. 12B differs from the embodiment of FIG. 11B in that delivery syringe 250 is not rotated to break notched frangible portion 240 and the entire haptics portion 202 is injected into the lens capsule.
  • As seen in FIGS. 12C-12D, following the injection of haptics portion 202 and optics portion 200, delivery syringe 250 is removed from the eye and outwardly extending helical portion 222 uncoils to its original form providing proper orientation of the implant, including fully deployed haptics spiral portion 236 of haptics portion 202 and optics portion 200, within the lens capsule.
  • Reference is now made to FIGS. 13A-13C, which illustrate an injectable intraocular implant constructed and operative in accordance with yet another preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 300 and a haptics portion 302 which is preferably snap-fitted onto the optics portion 300.
  • The optics portion 300 may be any suitable optics portion and is preferably, but not necessarily, a telescope. Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • U.S. Pat. Nos. 5,391,202; 5,354,335; 5,814,103; 5,876,442; 5,928,283; 6,007,579; 6,066,171; 6,569,199 and 6,596,026, and U.S. published applications U.S. Ser. Nos. 10/342,160 and 10/321,793.
  • The optics portion 300 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the inward facing end 310, a peripheral groove 312.
  • The haptics portion 302 is preferably formed of a resilient, flexible material, with a hollow, generally cylindrical structure defining a generally circular inward facing wall portion 314 and a generally circular outward facing wall portion 316. Each of wall portions 314 and 316 preferably define a generally circular optics engagement aperture 320 therein. Each of wall portions 314 and 316 is preferably formed with an inwardly directed peripheral protrusion 328 adjacent optics engagement aperture 320 thereof. Protrusion 328 of wall portion 314 is arranged for normally non-removable snap-fit engagement with groove 312 of optics portion 300, when haptics portion 302 is in coaxial surrounding relationship with optics portion 300 as shown.
  • Protrusion 328 of wall portion 316 is arranged for engagement of wall portion 316 with a delivery syringe as described further hereinbelow.
  • It is appreciated that while haptics portion 302 is preferably formed of a transparent material, it may be formed with non-transparent portions as suitable to eliminate and/or reduce glare.
  • Reference is now made to FIGS. 14A and 14B, which are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 13A-13C located in a delivery syringe and to FIGS. 15A, 15B, 15C and 15D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 13A-13C in the delivery syringe arrangement of FIGS. 14A & 14B into the eye of a patient.
  • As seen in FIGS. 14A-14B, prior to injection of the intraocular implant of FIGS. 13A-13C into an eye, outward facing wall portion 316 of haptics portion 302 is pulled over an outward facing end 330 of optics portion 300 and drawn into engagement with an outer wall 340 of a delivery syringe 350. As seen particularly in FIG. 14B, outer wall 340 preferably includes an inwardly directed peripheral protrusion 352 which engages protrusion 328 of wall portion 316 and thereby secures wall portion 316 of haptics portion 302 to delivery syringe 350. As seen further in FIGS. 14A-14B, the pulling of wall portion 316 causes haptics portion 302 to be temporarily deformed into an elongated generally cylindrical orientation overlying optics portion 300.
  • Delivery syringe 350 preferably also includes a fluid flow passageway 354 in fluid communication with a rearward facing wall 356 of syringe 350 at a location 358. Fluid flow passageway 354 is also preferably in fluid communication with a vacuum pump (not shown) via a tube 360.
  • As seen in FIG. 15A, prior to insertion of the injectable intraocular implant into the lens capsule, fluid flow passageway 354 is temporarily sealed by covering location 358, and the vacuum pump is operated to remove air contained within haptics portion 302. FIG. 15A shows initial insertion of delivery syringe 350 into the lens capsule of the eye. It is appreciated that the operation of the vacuum pump allows haptics portion 302 to closely overly optics portion 300.
  • As seen further in FIGS. 15B-15C, following placement of the implant into the lens capsule, haptics portion 302 of the implant expands outwardly from the optics portion 300 as wall portions 314 and 316 of haptics portion 302 return to their original generally circular orientation. As seen in FIG. 15B, the unsealing of fluid flow passageway 354 allows air to flow therethrough and into the space formed between haptics portion 302 and optics portion 300, causing expansion of haptics portion 302 and causing outer wall 340 of delivery syringe 350 to disengage from protrusion 328 of wall portion 316 of haptics portion 302.
  • As seen in FIG. 15D, following the injection of haptics portion 302 and optics portion 300, delivery syringe 350 is removed from the eye and haptics portion 302 returns to its original form providing proper orientation of the implant, including fully deployed haptics portion 302 and optics portion 300, within the lens capsule.
  • Reference is now made to FIGS. 16A-16C, which illustrate an injectable intraocular implant constructed and operative in accordance with yet another preferred embodiment of the present invention. It is seen that the implant preferably includes an optics portion 400 and a haptics portion 402 which is preferably snap-fitted or shrink-fitted onto the optics portion 400.
  • The optics portion 400 may be any suitable optics portion and is preferably, but not necessarily, a telescope. Preferred intraocular implants are described in applicants/assignee's published patent documents listed hereinbelow, the disclosures of which are hereby incorporated by reference:
  • U.S. Pat. Nos. 5,391,202; 5,354,335; 5,814,103; 5,876,442; 5,928,283; 6,007,579; 6,066,171; 6,569,199 and 6,596,026, and U.S. published applications U.S. Ser. Nos. 10/342,160 and 10/321,793.
  • The optics portion 400 may incorporate any one or more of the features described in the abovementioned patent documents in any suitable combination and is preferably in the form of a cylinder having adjacent one end thereof, hereinafter referred to as the inward facing end 410, a peripheral groove 412.
  • The haptics portion 402 is preferably formed of a resilient, flexible material, with a hollow, generally cylindrical structure defining a generally circular inward facing wall portion 414 and a generally circular outward facing wall portion 416. Wall portion 414 preferably defines a generally circular optics engagement aperture 420 therein. Wall portion 414 is preferably formed with an inwardly directed peripheral protrusion 428 adjacent optics engagement aperture 420. Protrusion 428 of wall portion 414 is arranged for normally non-removable snap-fit or tension-fit engagement with groove 412 of optics portion 400, when haptics portion 402 is in coaxial surrounding relationship with optics portion 400 as shown.
  • It is appreciated that while haptics portion 402 is preferably formed of a transparent material, it may be formed with non-transparent portions as suitable to eliminate and/or reduce glare.
  • Reference is now made to FIGS. 17A and 17B, which are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a delivery syringe and to FIGS. 18A, 18B, 18C and 18D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 17A & 17B into the eye of a patient.
  • As seen in FIGS. 17A-17B, prior to injection of the intraocular implant of FIGS. 16A-16C into an eye, outward facing wall portion 416 of haptics portion 402 is drawn into a vacuum delivery syringe 450 by extending a plunger 456 in the direction of arrow 458. As seen in FIGS. 17A-17B, the drawing of wall portion 416 into delivery syringe 450 causes haptics portion 402 to be temporarily deformed into an elongated generally cylindrical orientation overlying optics portion 400.
  • FIG. 18A shows initial insertion of delivery syringe 450 into the lens capsule of the eye, in the direction of arrow 460. It is appreciated that maintaining plunger 456 in the position of FIGS. 17A-17B maintains the vacuum inside delivery syringe 450 and allows haptics portion 402 to closely overly optics portion 400 during initial insertion of syringe 450 into the lens capsule.
  • As seen further in FIG. 18B, following placement of the implant into the lens capsule, plunger 456 is pushed in the direction of arrow 464 and haptics portion 402 of the implant is released from syringe 450. Following release of the implant from delivery syringe 450, haptics portion 402 expands outwardly from the optics portion 400 as wall portions 414 and 416 of haptics portion 402 return to their original generally circular orientation.
  • As seen further in FIG. 18C, following release of the implant and removal of delivery syringe 450, an aperture is made in wall portion 416, preferably through puncturing wall portion 416 with a hook 468, to allow aqueous fluid from the eye to flow into the area between optics portion 400 and haptics portion 402. As seen further in FIG. 18D, following the removal of hook 468, haptics portion 402 fills with aqueous fluid 470 and returns to its original form providing proper orientation of the implant, including fully deployed haptics portion 402 and optics portion 400, within the lens capsule.
  • Reference is now made to FIGS. 19A and 19B, which are simplified pictorial and sectional illustrations of the injectable intraocular implant of FIGS. 16A-16C located in a fluid-filled delivery syringe and to FIGS. 20A, 20B, 20C and 20D, which are simplified sectional illustrations of four stages of the injection of the intraocular implant of FIGS. 16A-16C in the delivery syringe arrangement of FIGS. 19A & 19B into the eye of a patient.
  • As seen in FIGS. 19A-19B, prior to injection of the intraocular implant of FIGS. 16A-16C into an eye, outward facing wall portion 416 of haptics portion 402 is pulled over an outward facing end 490 of optics portion 400 and the intraocular implant is inserted into a fluid-filled delivery syringe 500. As seen in FIGS. 19A-19B, the pulling of wall portion 416 over end 490 causes haptics portion 402 to be temporarily deformed into an elongated generally cylindrical orientation overlying optics portion 400. Fluid, such as biocompatible fluid 504, is located forward of a piston 506 of delivery syringe 500 and rearward of the implant.
  • It is appreciated that haptics portion 402 may be filled, using any suitable method, with any suitable biocompatible fluid 510, such as saline or air, prior to insertion into delivery syringe 500. It is further appreciated that insertion of fluid 510 into haptics portion 402 provides cushioning for the intraocular implant during the injection thereof into an eye.
  • FIG. 20A shows initial insertion of the tip of delivery syringe 500 into the lens capsule of the eye. It is appreciated that the temporary deforming of haptics portion 402 allows haptics portion 402 to closely overly optics portion 400 inside syringe 500.
  • As seen further in FIG. 20B, following placement of the delivery syringe 500 into the lens capsule, the implant is forced out of the syringe 500 into the lens capsule. As seen in FIG. 20B, haptics portion 402 expands outwardly from the optics portion 400 as wall portions 414 and 416 of haptics portion 402 return to their generally circular orientation. Syringe 500 is subsequently removed from the lens capsule.
  • As seen further in FIG. 20C, an aperture is made in wall portion 416, preferably through puncturing wall portion 416 with a hook 518, to allow aqueous fluid from the eye to flow into the area between optics portion 400 and haptics portion 402 and mix with biocompatible fluid 510. Alternatively, haptics portion 402 is not filled with biocompatible fluid 510 prior to insertion into delivery syringe 500 and the puncturing of wall portion 416 allows aqueous fluid from the eye to flow into the area between optics portion 400 and haptics portion 402.
  • As seen further in FIG. 20D, following the removal of hook 518, haptics portion 402 returns to its original form providing proper orientation of the implant, including fully deployed haptics portion 402 and optics portion 400, within the lens capsule.
  • It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather the scope of the present invention includes both combinations and subcombinations of features described hereinabove as well as variations and modifications thereof which would occur to a person skilled in the art upon reading the foregoing description, taken together with the drawings, and which are not in the prior art.

Claims (23)

1. An injectable intraocular implant comprising:
an optics portion; and
a resilient, flexible haptics portion mounted coaxially with said optics portion, said haptics portion comprising a hollow, generally cylindrical structure defining a generally circular inward facing wall portion and a generally circular outward facing wall portion.
2. An injectable intraocular implant according to claim 1 and wherein said optics portion and said haptics portion are arranged for mutual snap fit engagement.
3. An injectable intraocular implant according to claim 1 and wherein said optics portion comprises a telescope.
4. An injectable intraocular implant according to claim 1 and wherein said haptics portion is formed of biocompatible plastic.
5-8. (canceled)
9. An injectable intraocular implant according to claim 1 and wherein said inward facing wall portion defines a generally circular optics engagement aperture therein.
10. An injectable intraocular implant according to claim 1 and wherein said inward facing wall portion and said outward facing wall portion each define a generally circular optics engagement aperture therein.
11. A method for inserting an intraocular implant into an eye comprising:
providing an injectable intraocular implant including:
an optics portion; and
a resilient, flexible haptics portion mounted coaxially with said optics portion, said haptics portion comprising a hollow, generally cylindrical structure defining a generally circular inward facing wall portion and a generally circular outward facing wall portion;
locating said injectable intraocular implant in a delivery tube of a syringe;
inserting said delivery tube into a lens capsule of an eye; and
injecting said injectable intraocular implant into said lens capsule.
12. A method according to claim 11 and wherein said injecting comprises utilizing fluid pressure to force said implant into said lens capsule.
13-18. (canceled)
19. A method according to claim 11 and wherein said locating includes pulling said outward facing wall portion over an outward facing end of said optics portion.
20. A method according to claim 11 and wherein said locating includes sealing a fluid flow passageway in said syringe.
21. A method according to claim 20 and wherein said injecting includes unsealing said fluid flow passageway.
22. A method according to claim 11 and wherein said locating includes drawing said haptics portion into a delivery syringe.
23. A method according to claim 11 and also comprising puncturing said haptics portion.
24. A method according to claim 11 and wherein said providing also comprises filling said haptics portion with a biocompatible fluid.
25. An injectable intraocular implant according to claim 1 and wherein said optics portion is generally cylindrical and has a peripheral groove formed thereon.
26. An injectable intraocular implant according to claim 25 and wherein at said inward facing wall portion is formed with an inwardly directed peripheral protrusion adapted for snap-fit engagement with said peripheral groove of said optics portion.
27. An injectable intraocular implant according to claim 26 and wherein said inwardly directed peripheral protrusion and said peripheral groove are adapted for snap-fit engagement when said haptics portion is in coaxial surrounding relationship with said optics portion.
28. An injectable intraocular implant according to claim 1 and wherein at said outward facing wall portion is formed with an inwardly directed peripheral protrusion adapted for engagement of said outward facing wall portion with a delivery syringe.
29. An injectable intraocular implant according to claim 1 and wherein said haptics portion includes at least one non-transparent portion adapted to reduce glare.
30. An injectable intraocular implant according to claim 1 and wherein said haptics portion is adapted to be shrink-fitted onto said optics portion.
31. An injectable intraocular implant according to claim 1 and wherein said haptics portion is filled with a biocompatible fluid.
US13/338,440 2005-07-28 2011-12-28 Compressed haptics Abandoned US20120095554A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/338,440 US20120095554A1 (en) 2005-07-28 2011-12-28 Compressed haptics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/193,781 US8088161B2 (en) 2005-07-28 2005-07-28 Compressed haptics
US13/338,440 US20120095554A1 (en) 2005-07-28 2011-12-28 Compressed haptics

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/193,781 Division US8088161B2 (en) 2005-07-28 2005-07-28 Compressed haptics

Publications (1)

Publication Number Publication Date
US20120095554A1 true US20120095554A1 (en) 2012-04-19

Family

ID=37218148

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/193,781 Active 2030-11-02 US8088161B2 (en) 2005-07-28 2005-07-28 Compressed haptics
US11/996,707 Active 2027-08-30 US8133273B2 (en) 2005-07-28 2006-07-27 Injectable intraocular implants
US13/338,440 Abandoned US20120095554A1 (en) 2005-07-28 2011-12-28 Compressed haptics

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/193,781 Active 2030-11-02 US8088161B2 (en) 2005-07-28 2005-07-28 Compressed haptics
US11/996,707 Active 2027-08-30 US8133273B2 (en) 2005-07-28 2006-07-27 Injectable intraocular implants

Country Status (9)

Country Link
US (3) US8088161B2 (en)
EP (3) EP1747768B1 (en)
JP (2) JP4829300B2 (en)
AT (1) ATE444034T1 (en)
CA (2) CA2616736C (en)
DE (1) DE602006009443D1 (en)
ES (3) ES2334257T3 (en)
IL (1) IL176567A0 (en)
WO (1) WO2007013080A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3560457A1 (en) 2018-04-26 2019-10-30 VisionCare, Inc. Apparatus for use in implanting intraocular lenses and method of preparing apparatus for use

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668735B2 (en) 2000-09-12 2014-03-11 Revision Optics, Inc. Corneal implant storage and delivery devices
US6543610B1 (en) * 2000-09-12 2003-04-08 Alok Nigam System for packaging and handling an implant and method of use
IL145015A0 (en) * 2001-08-21 2002-06-30 Nun Yehoshua Ben Accommodating lens
US20070100445A1 (en) * 2003-02-03 2007-05-03 Shadduck John H Intraocular lenses and business methods
US8361145B2 (en) 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US20060259049A1 (en) * 2003-03-17 2006-11-16 Sumitomo Bakelite Co., Ltd. Clip and clipping instrument for biological tissues
IL161706A0 (en) * 2004-04-29 2004-09-27 Nulens Ltd Intraocular lens fixation device
US20080262610A1 (en) * 2007-04-20 2008-10-23 Alan Lang Biomechanical design of intracorneal inlays
US8057541B2 (en) * 2006-02-24 2011-11-15 Revision Optics, Inc. Method of using small diameter intracorneal inlays to treat visual impairment
US10835371B2 (en) 2004-04-30 2020-11-17 Rvo 2.0, Inc. Small diameter corneal inlay methods
US20110218623A1 (en) * 2004-04-30 2011-09-08 Jon Dishler Small Diameter Inlays
US7815678B2 (en) * 2004-10-13 2010-10-19 Nulens Ltd. Accommodating intraocular lens (AIOL), and AIOL assemblies including same
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
US8029515B2 (en) * 2005-01-31 2011-10-04 Yichieh Shiuey Corneal implants and methods and systems for placement
US20080300680A1 (en) * 2005-03-30 2008-12-04 Nulens Ltd Accommodating Intraocular Lens (Aiol) and Discrete Components Therefor
US8034107B2 (en) * 2005-09-01 2011-10-11 Stenger Donald C Accommodating intraocular lens
US20070129797A1 (en) * 2005-12-01 2007-06-07 Revision Optics, Inc. Intracorneal inlays
US10555805B2 (en) 2006-02-24 2020-02-11 Rvo 2.0, Inc. Anterior corneal shapes and methods of providing the shapes
US20070255401A1 (en) * 2006-05-01 2007-11-01 Revision Optics, Inc. Design of Inlays With Intrinsic Diopter Power
US20070280994A1 (en) * 2006-06-01 2007-12-06 Cunanan Crystal M Ocular Tissue Separation Areas With Barrier Regions For Inlays Or Other Refractive Procedures
US20090198247A1 (en) * 2006-08-25 2009-08-06 Nulens Ltd. Intraocular lens implantation kit
USD702346S1 (en) 2007-03-05 2014-04-08 Nulens Ltd. Haptic end plate for use in an intraocular assembly
ATE483427T1 (en) * 2007-03-05 2010-10-15 Nulens Ltd UNIFORM ACCOMMODATION INTRAOCULAR LENSES (AIOLS) AND DISCRETE BASE ELEMENTS FOR USE THEREWITH
US9549848B2 (en) 2007-03-28 2017-01-24 Revision Optics, Inc. Corneal implant inserters and methods of use
US8162953B2 (en) 2007-03-28 2012-04-24 Revision Optics, Inc. Insertion system for corneal implants
US9271828B2 (en) 2007-03-28 2016-03-01 Revision Optics, Inc. Corneal implant retaining devices and methods of use
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
US8668734B2 (en) 2010-07-09 2014-03-11 Powervision, Inc. Intraocular lens delivery devices and methods of use
WO2009015226A2 (en) 2007-07-23 2009-01-29 Powervision, Inc. Accommodating intraocular lenses and methods of use
EP2647353B1 (en) * 2007-07-23 2014-12-31 PowerVision, Inc. Lens delivery system
EP2178462B1 (en) * 2007-07-23 2014-04-02 PowerVision, Inc. Post-implant lens power modification
US9539143B2 (en) 2008-04-04 2017-01-10 Revision Optics, Inc. Methods of correcting vision
WO2009124268A2 (en) * 2008-04-04 2009-10-08 Revision Optics, Inc. Corneal inlay design and methods of correcting vision
ES2377456T3 (en) * 2008-07-24 2012-03-27 Nulens Ltd Accommodative intraocular lens capsules (IOLs)
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
US9421127B2 (en) 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
TWI495459B (en) * 2009-03-31 2015-08-11 Johnson & Johnson Vision Care Punctal plugs
JP2013520291A (en) 2010-02-23 2013-06-06 パワーヴィジョン・インコーポレーテッド Liquid for accommodation type intraocular lens
US9259352B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9220590B2 (en) 2010-06-10 2015-12-29 Z Lens, Llc Accommodative intraocular lens and method of improving accommodation
US8469948B2 (en) 2010-08-23 2013-06-25 Revision Optics, Inc. Methods and devices for forming corneal channels
WO2012129407A2 (en) 2011-03-24 2012-09-27 Powervision, Inc. Intraocular lens loading systems and methods of use
CN103998932B (en) 2011-06-29 2017-06-06 中央研究院 Capture, purifying and release using face coat to biological substance
WO2013059813A1 (en) 2011-10-21 2013-04-25 Revision Optics, Inc. Corneal implant storage and delivery devices
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
US8900300B1 (en) 2012-02-22 2014-12-02 Omega Ophthalmics Llc Prosthetic capsular bag and method of inserting the same
WO2013142323A1 (en) * 2012-03-21 2013-09-26 Powervision, Inc. Intraocular lens delivery systems and methods of use
US9364318B2 (en) 2012-05-10 2016-06-14 Z Lens, Llc Accommodative-disaccommodative intraocular lens
TR201205918A2 (en) * 2012-05-21 2012-10-22 Oruçoğlu Fai̇k Intraocular lens.
US9107728B2 (en) * 2012-09-23 2015-08-18 Mark Philip Breazzano Eyeball stabilizing apparatus and method of use
US9494500B2 (en) 2012-10-29 2016-11-15 Academia Sinica Collection and concentration system for biologic substance of interest and use thereof
EP3785668A1 (en) 2013-03-15 2021-03-03 Alcon Inc. Intraocular lens storage and loading devices and methods of use
USD733873S1 (en) * 2013-05-07 2015-07-07 Novian Health Inc. Probe holder
EP3126814B1 (en) 2014-04-01 2019-06-12 Academia Sinica Methods and systems for cancer diagnosis and prognosis
CA2952809C (en) 2014-06-19 2019-11-26 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
CN105381824B (en) 2014-08-26 2019-04-23 中央研究院 Collector framework layout designs
US9358103B1 (en) 2015-02-10 2016-06-07 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
WO2016144404A1 (en) 2015-03-12 2016-09-15 Revision Optics, Inc. Methods of correcting vision
JP6590947B2 (en) * 2015-04-19 2019-10-16 アトリオン・コーポレイションAtrion Corporation Spring powered / hydraulic pressure operated intraocular lens insertion device
WO2017079733A1 (en) 2015-11-06 2017-05-11 Powervision, Inc. Accommodating intraocular lenses and methods of manufacturing
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
IL245775A0 (en) 2016-05-22 2016-08-31 Joshua Ben Nun Hybrid accommodating intraocular lens
CA3024891A1 (en) 2016-05-31 2017-12-07 Qura, Inc. Implantable intraocular pressure sensors and methods of use
CA3026494C (en) 2016-06-06 2022-06-07 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
JP7074960B2 (en) 2016-08-24 2022-05-25 カール ツァイス メディテック アーゲー Dual Mode Adjustable-Non-Adjustable Intraocular Lens
EP3954326A1 (en) 2016-10-21 2022-02-16 Omega Ophthalmics LLC Prosthetic capsular device
AU2019249216A1 (en) 2018-04-06 2020-10-01 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods
GB2578639A (en) 2018-11-02 2020-05-20 Rayner Intraocular Lenses Ltd Hybrid accommodating intraocular lens assemblages including discrete lens unit with segmented lens haptics
WO2022082170A1 (en) 2020-10-12 2022-04-21 Omega Ophthalmics Llc Prosthetic capsular devices, systems, and methods

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693716A (en) * 1984-08-21 1987-09-15 Mackool Richard J Multipartite intraocular lens
US5074876A (en) * 1987-12-04 1991-12-24 Kelman Charles D Two piece intraocular lens
US5391202A (en) * 1993-02-04 1995-02-21 Lipshitz; Isaac Intraocular insert for implantation in the human eye
US6007579A (en) * 1998-01-15 1999-12-28 Visioncare Ltd. Intraocular carrying member with attachment for telescope
US6277146B1 (en) * 1999-09-16 2001-08-21 Gholam A. Peyman Glare-free intraocular lens and method for using the same
US20020138140A1 (en) * 2000-02-16 2002-09-26 Khalil Hanna Intraocular implant and an artificial lens device

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515461A (en) * 1967-01-30 1970-06-02 Perkin Elmer Corp Catadioptric objective of the cassegrain type
DE2016378A1 (en) 1970-04-06 1971-11-04 Mengeier, Hermann, Dr., 4000 Düsseldorf Process for artificial vision and eye prosthesis for performing this process
US4172297A (en) 1976-02-24 1979-10-30 Inprohold Establishment Artificial implant lens
US4056855A (en) * 1976-04-07 1977-11-08 Charles Kelman Intraocular lens and method of implanting same
US4074368A (en) 1976-09-08 1978-02-21 Said Chauncey F. Levy, Jr., By Said Richard J. Pegis Intraocular lens with high magnification
US4373218A (en) 1980-11-17 1983-02-15 Schachar Ronald A Variable power intraocular lens and method of implanting into the posterior chamber
US4710197A (en) 1981-10-30 1987-12-01 Anthony Donn Intraocular-external lens combination system and method of using same
US4573998A (en) * 1982-02-05 1986-03-04 Staar Surgical Co. Methods for implantation of deformable intraocular lenses
US4463458A (en) 1982-11-08 1984-08-07 Vision Laboratories Inc. Intraocular lens and implantation method
US4687484A (en) 1983-12-12 1987-08-18 Kaplan Linda J Anterior chamber intraocular lens
US4527294A (en) 1983-12-16 1985-07-09 Heslin K B Intraocular lens construction
US4596578A (en) 1984-01-30 1986-06-24 Kelman Charles D Intraocular lens with miniature optic
EP0162573A3 (en) 1984-04-17 1986-10-15 Sanford D. Hecht Eye implant
US4581031A (en) 1984-06-22 1986-04-08 Koziol Jeffrey E Prismatic intraocular lens
DE3428895C2 (en) 1984-08-04 1986-07-10 Dr. K. Schmidt-Apparatebau, 5205 St Augustin Artificial intraocular lens
US4976732A (en) 1984-09-12 1990-12-11 International Financial Associates Holdings, Inc. Optical lens for the human eye
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4743254A (en) 1985-01-31 1988-05-10 American Hospital Supply Company Small incision intraocular lens
US4731078A (en) 1985-08-21 1988-03-15 Kingston Technologies Limited Partnership Intraocular lens
IT1197356B (en) 1985-10-15 1988-11-30 Storz Instr Co INTRAOCULAR LENSES WITH ANTI-GLARE EDGES
US4759761A (en) 1986-03-13 1988-07-26 Allergan, Inc. Catadioptric intraocular lens
US4666446A (en) 1986-05-06 1987-05-19 Koziol Jeffrey E Intraocular lens with converging and diverging optical portions
US4911714A (en) 1987-03-26 1990-03-27 Poley Brooks J Foldable intraocular lens and improved fold retaining means
US4816030A (en) 1987-07-13 1989-03-28 Robinson Paul J Intraocular lens
US4833890A (en) * 1988-04-04 1989-05-30 Kelman Charles D Bipartite intraocular lens
US4994082A (en) 1988-09-09 1991-02-19 Ophthalmic Ventures Limited Partnership Accommodating intraocular lens
US4968127A (en) 1988-11-23 1990-11-06 Russell James P Controllable, variable transmissivity eyewear
US5044743A (en) * 1988-12-20 1991-09-03 Allergan, Inc. Corrective lens system
US4892543A (en) 1989-02-02 1990-01-09 Turley Dana F Intraocular lens providing accomodation
US4911715A (en) 1989-06-05 1990-03-27 Kelman Charles D Overlapping two piece intraocular lens
EP0419740A1 (en) 1989-09-27 1991-04-03 HANITA LENSES (a Limited Partnership) Negative-power intraocular lens
US5026396A (en) 1990-05-07 1991-06-25 Darin John J Two-piece intraocular lens
US5108429A (en) 1991-03-11 1992-04-28 Wiley Robert G Micromotor actuated adjustable focus lens
FR2666735A1 (en) 1990-09-13 1992-03-20 Klw Intraocular implant with internal cavity
US5222981A (en) 1991-08-15 1993-06-29 Werblin Research & Development Corp. Multi-component intraocular lens
US5190552A (en) * 1992-02-04 1993-03-02 Kelman Charles D Slotted tube injector for an intraocular lens
US5384606A (en) 1992-06-22 1995-01-24 Allergan, Inc. Diffractive/refractive spectacle and intraocular lens system for age-related macular degeneration
US5616148A (en) * 1992-09-30 1997-04-01 Staar Surgical Company, Inc. Transverse hinged deformable intraocular lens injecting apparatus
ES2132259T3 (en) 1992-10-02 1999-08-16 Nestle Sa INTRAOCULAR LENS SYSTEM.
IT1262909B (en) 1992-10-13 1996-07-22 INTRAOCULAR LENS
US5275604A (en) * 1992-12-03 1994-01-04 Kabi Pharmacia Ophthalmics, Inc. Contoured duct apparatus and method for insertion of flexible intraocular lens
DE4403326C1 (en) 1994-02-03 1995-06-22 Hans Reinhard Prof Dr Koch Intraocular lens arrangement for astigmatism correction
JPH0876067A (en) * 1994-09-09 1996-03-22 Menicon Co Ltd Intra-ocular lens and its production
US5653751A (en) 1994-12-07 1997-08-05 Samiy; Nassrollah Systems and methods for projecting an image onto a retina
US6358280B1 (en) * 1994-12-08 2002-03-19 Herrick Family Limited Partnership A California Limited Partnership Artificial lens including a lens system having eccentric axes for use in an eye having an enlarged pupil
DE19501444A1 (en) 1995-01-19 1996-07-25 Morcher Gmbh Intra ocular two lens system
FR2735680B1 (en) * 1995-06-22 1998-01-02 W K Et Associes INTRAOCULAR IMPLANT DEVICE FOR CORRECTING OCULAR ANISOTROPY
US5728155A (en) 1996-01-22 1998-03-17 Quantum Solutions, Inc. Adjustable intraocular lens
US20040148022A1 (en) 1996-03-18 2004-07-29 Eggleston Harry C. Modular intraocular implant
US5628798A (en) 1996-03-18 1997-05-13 Harry C. Eggleston Adjustable and removable intraocular lens implant
US5769889A (en) 1996-09-05 1998-06-23 Kelman; Charles D. High myopia anterior chamber lens with anti-glare mask
US5944725A (en) * 1996-09-26 1999-08-31 Bausch & Lomb Surgical, Inc. Method and apparatus for inserting a flexible membrane into an eye
US5769890B1 (en) 1997-01-16 2000-09-05 Surgical Concepts Inc Placement of second artificial lens in eye to correct for optical defects of first artificial lens in eye
DE19707046A1 (en) * 1997-02-21 1998-08-27 Rolf Prof Dr Ing Eckmiller Learnable "Active Vision" implant encoder
US5928283A (en) 1997-06-26 1999-07-27 Visioncare Ltd Telescopic device for an intraocular lens
US20010018612A1 (en) 1997-08-07 2001-08-30 Carson Daniel R. Intracorneal lens
US5814103A (en) 1998-01-15 1998-09-29 Visioncare Ltd. Intraocular lens and telescope with mating fasteners
US5876442A (en) 1998-01-15 1999-03-02 Visioncare Ltd. Intraocular lens implant with telescope support
US6066171A (en) 1998-06-01 2000-05-23 Visioncare Ltd. Intraocular lens with pivoting telescope
EP1100412A1 (en) 1998-07-24 2001-05-23 Johns Hopkins University School of Medicine Fluid modulated intraocular lens
US6197057B1 (en) 1998-10-27 2001-03-06 Gholam A. Peyman Lens conversion system for teledioptic or difractive configurations
JP2000189446A (en) * 1998-12-25 2000-07-11 ▲桜▼井精技株式会社 Structure of intraocular lens and control of focal distance
ATE277569T1 (en) 1998-12-29 2004-10-15 Visioncare Ophthalmic Tech Inc TELESCOPIC INTRAOCULAR LENS
US8180453B2 (en) * 1999-03-24 2012-05-15 Second Sight Medical Products, Inc. Electrode array for neural stimulation
US20030060881A1 (en) 1999-04-30 2003-03-27 Advanced Medical Optics, Inc. Intraocular lens combinations
EP1178763B1 (en) * 1999-05-07 2008-12-10 Retina Implant AG Retina implant and method for producing the same
FR2799637B1 (en) 1999-10-13 2002-04-12 Ioltechnologie Production PRISMATIC INTRAOCULAR IMPLANT FOR POSTERIOR EYE CHAMBER
US6387101B1 (en) * 1999-10-22 2002-05-14 Staar Surgical Company, Inc. Deformable intraocular lens injecting apparatus and method
US6342073B1 (en) * 1999-12-30 2002-01-29 J. Stuart Cumming Intraocular lens for posterior vaulting
US6500181B1 (en) * 2000-10-17 2002-12-31 Valdemar Portney Instrument for folding and inserting anterior chamber intraocular lenses
US6596026B1 (en) 2000-11-27 2003-07-22 Visioncare Ophthalmic Technologies, Inc. Telescopic intraocular lens
US6464725B2 (en) 2001-01-23 2002-10-15 Bernt Christian Skotton Two-lens adjustable intraocular lens system
US7198640B2 (en) 2001-01-25 2007-04-03 Visiogen, Inc. Accommodating intraocular lens system with separation member
AU2002240147A1 (en) 2001-02-01 2002-08-12 Tekia, Inc. Two part "l"- or "s"-shaped phakic iol
US20030105522A1 (en) 2001-06-11 2003-06-05 Glazier Alan N. Multi-focal intraocular lens
US7229475B2 (en) 2001-06-11 2007-06-12 Vision Solutions Technologies, Inc. Multi-focal intraocular lens, and methods for making and using same
US6537283B2 (en) * 2001-08-17 2003-03-25 Alcon, Inc. Intraocular lens shipping case and injection cartridge
IL145015A0 (en) 2001-08-21 2002-06-30 Nun Yehoshua Ben Accommodating lens
US6623522B2 (en) 2001-11-07 2003-09-23 Alok Nigam Myopic corneal ring with central accommodating portion
US7097660B2 (en) 2001-12-10 2006-08-29 Valdemar Portney Accommodating intraocular lens
FR2833154B1 (en) * 2001-12-12 2004-11-19 Ioltechnologie Production CASSETTE AND FLEXIBLE INTRAOCULAR LENS INJECTOR AND METHOD FOR INJECTING SUCH LENSES
US6902577B2 (en) 2002-03-29 2005-06-07 Isaac Lipshitz Intraocular lens implant with mirror
US7008448B2 (en) 2002-03-29 2006-03-07 Isaac Lipshitz Intraocular implant for retinal diseases
US6913620B2 (en) 2002-03-29 2005-07-05 Isaac Lipshitz Intraocular lens implant with mirror
CA2769703A1 (en) * 2002-07-26 2004-02-19 Amo Groningen B.V. Method and device for manipulation of an intraocular lens
US7001427B2 (en) * 2002-12-17 2006-02-21 Visioncare Ophthalmic Technologies, Inc. Intraocular implants
US6972032B2 (en) * 2003-01-14 2005-12-06 Visioncare Ophthalmic Technologies Inc. Intraocular lens implant
EP1475055B1 (en) 2003-05-07 2010-04-28 Visioncare Ophthalmic Technologies, Inc. Telescopic intraocular lens
JP4038454B2 (en) 2003-07-31 2008-01-23 株式会社ニデック Intraocular lens
IL157979A0 (en) * 2003-09-17 2004-03-28 Hanita Lenses Packaging system for intraocular lens
US20050149057A1 (en) * 2003-12-22 2005-07-07 Rathert Brian D. IOL inserter plunger and body interface

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693716A (en) * 1984-08-21 1987-09-15 Mackool Richard J Multipartite intraocular lens
US5074876A (en) * 1987-12-04 1991-12-24 Kelman Charles D Two piece intraocular lens
US5391202A (en) * 1993-02-04 1995-02-21 Lipshitz; Isaac Intraocular insert for implantation in the human eye
US6007579A (en) * 1998-01-15 1999-12-28 Visioncare Ltd. Intraocular carrying member with attachment for telescope
US6277146B1 (en) * 1999-09-16 2001-08-21 Gholam A. Peyman Glare-free intraocular lens and method for using the same
US20020138140A1 (en) * 2000-02-16 2002-09-26 Khalil Hanna Intraocular implant and an artificial lens device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3560457A1 (en) 2018-04-26 2019-10-30 VisionCare, Inc. Apparatus for use in implanting intraocular lenses and method of preparing apparatus for use
US10925722B2 (en) 2018-04-26 2021-02-23 Visioncare Inc. Apparatus for use in implanting intraocular lenses and method of preparing apparatus for use

Also Published As

Publication number Publication date
CA2616736C (en) 2014-04-08
JP2009502305A (en) 2009-01-29
JP2007044506A (en) 2007-02-22
IL176567A0 (en) 2006-10-31
US8088161B2 (en) 2012-01-03
EP3488820B1 (en) 2021-09-01
JP4829300B2 (en) 2011-12-07
EP1909697B1 (en) 2018-11-28
US20090036982A1 (en) 2009-02-05
US20070027538A1 (en) 2007-02-01
ES2713035T3 (en) 2019-05-17
EP1909697A2 (en) 2008-04-16
EP1909697A4 (en) 2014-07-16
EP3488820A1 (en) 2019-05-29
ES2334257T3 (en) 2010-03-08
US8133273B2 (en) 2012-03-13
CA2554303C (en) 2015-02-10
CA2554303A1 (en) 2007-01-28
EP1747768B1 (en) 2009-09-30
CA2616736A1 (en) 2007-02-01
WO2007013080A2 (en) 2007-02-01
ATE444034T1 (en) 2009-10-15
ES2899299T3 (en) 2022-03-10
DE602006009443D1 (en) 2009-11-12
EP1747768A1 (en) 2007-01-31
WO2007013080A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
US8088161B2 (en) Compressed haptics
AU2019261747B2 (en) Intraocular lens delivery systems and methods of use
CN101754728B (en) Lens delivery system
JP4559456B2 (en) Lens delivery system
CN102316824B (en) Automated intraocular lens injector device
ES2332674T3 (en) CARTRIDGE OF LENS ADMINISTRATION SYSTEM AND MANUFACTURING PROCEDURE.
MXPA01008490A (en) Device for injecting an intraocular lens made of flexible material.
ES2323315T3 (en) AUTOINJECTOR WITH AN EXTENSIBLE NEEDLE PROTECTIVE CASE.
US20040117012A1 (en) Injector for an intraocular lens
JP2006517837A (en) Method and device for compressing an intraocular lens
US20030181921A1 (en) Flexible intraocular implant injector
WO2003026531A3 (en) Stent delivery system
CN102985030A (en) Improved intraocular lens injecting apparatus
CN105517619A (en) Balloon catheter
WO2013061888A1 (en) Capsule, and cigarette with filter using same
FR2727855A1 (en) CAVERNOR EXTENSION IMPLANTS

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION